REFERENCES
- Klimas NG, O’Brien Knoneru A: Chronic fatigue syndrome: Inflammation, immune function, and neuroendocrine interactions. Curr Rheumatology Rep 9: 482–487, 2007.
- Viner R, Hotopf M: Childhood predictors of self reported chronic fatigue syndrome/myalgic encephalomyelitis in adults: National birth cohort study. BMJ 329: 941, 2004.
- Shepherd C, Chaudhuri A: Severely affected patients. ME/CFS/PVFS: An Exploration of the Key Clinical Issues, 2nd ed. Austin Rose Printers, Cambridgeshire, UK, 2005, pp. 17–18.
- Kaushik N, Fear D, Richards SCM, McDermott CR, Nuwaysir EF, Kellam P, : Gene expression in peripheral blood mononuclear cells from patients with chronic fatigue syndrome. J Clin Pathol 58: 826–832, 2005.
- Kerr JR, Christian P, Hodgetts A, Langford PR, Devanu LD, Petty R, : Current research priorities in chronic fatigue syndrome/myalgic encephalomyelitis: Disease mechanisms, a diagnostic test and specific treatments. J Clin Pathol 60: 113–116, 2007.
- Fukuda K, Straus S, Hickie I, Sharpe MC, Dobbins JG, Komaroff A: The chronic fatigue syndrome: A comprehensive approach to its definition and study. Ann Intern Med 121: 953–959, 1994.
- Jason LA, Richman JA, Rademaker AW, Jordan KM, Plioplys AV, Taylor RR, : A community-based study of chronic fatigue syndrome. Arch Inter Med 159: 2129–2137, 1999.
- Goldenberg DL, Simms RW, Geiger A, Komaroff AL: High frequency of fibromyalgia in patients with chronic fatigue seen in primary care practice. Arthritis rheum 33: 381–387, 1990.
- Buchwald D: Fibromyalgia and chronic fatigue syndrome, similarities and differences. Rheum Dis Clin North Am 22: 219–243, 1996.
- Bradley LA, McKendree-Smith N, Alarcon GS: Pain complaints in patients with fibromyalgia versus chronic fatigue syndrome. Curr Rev Pain 4: 148–157, 2000.
- Evengard B, Nilsson CG, Lindh G, Lindquist L, Eneroth P, Fredrikson S, : Chronic fatigue syndrome differs from fibromyalgia. No evidence for elevated substance P levels in cerebrospinal fluid of patients with chronic fatigue syndrome. Pain 78: 153–155, 1988.
- Meeus M, Mijs J, Van De Wauwer N, Toeback L, Truijen S: Diffuse noxious inhibitory control is delayed in chronic fatigue syndrome: An experimental study. Pain 139: 439–448, 2008.
- Julien N, Goffaux P, Arsenault P, Marchand S: Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition. Pain 114: 295–302, 2005.
- Costa DC, Tannock C, Brostoff J: Brainstem perfusion is impaired in chronic fatigue syndrome. QJM 88: 767–773, 1995.
- Vecchiet J, Cipollone F, Falasca K, Mezzetti A, Pizzigallo E, Bucciarelli T, : Relationship between musculoskeletal symptoms and blood markers of oxidative stress in patients with chronic fatigue syndrome. Neurosci Lett 335: 151–154, 2003.
- Kennedy G, Spence VA, McLaren M, Hill A, Underwood C, Belch JJ: Oxidative stress levels are raised in chronic fatigue syndrome and are associated with clinical symptoms. Free Radical Biol Med 39: 584–589, 2005.
- Lindal E, Bergman S, Thorlacius S, Stefannsson JG: The localization of pain in chronic fatigue syndrome on a pain drawing according to grid areas. Percept Mot Skills 83: 508–510, 1996.
- Carruthers BM, Kumar Jain A, De Meirleir KL, Peterson DL, Klimas NG, Lerner AM, : Myalgic encephalomyelitis/chronic fatigue syndrome: Clinical working case definition, diagnostic, and treatment protocols. J Chronic Fatigue Syndr 11: 7–115, 2003.
- Turk D, Melzack R: Handbook of Pain Assessment, 2nd ed. Guilford Press. New York, 2001, pp. 20–21.
- Margolis R, Tait R, Krause S: A rating system for use with patient pain drawings. Pain 24: 57–65, 1986.
- Melzack R: The McGill pain questionnaire: Major properties and scoring methods. Pain 1: 275–299, 1975.
- McDowell I: Measuring Health, 3rd ed. Oxford University Press, New York, 2006, pp. 483–489.
- Dubuisson D, Melzack R: Classification of clinical pain descriptions by multiple group discriminant analysis. Exp Neurol 51: 480–487, 1976.
- Melzack R, Terrence C, Fromm G, Amsel R: Trigeminal neuralgia and atypical facial pain: Use of the McGill pain questionnaire for discrimination and diagnosis. Pain 27: 297–302, 1986.
- Cohen MM, Tate RB: Using the McGill pain questionnaire to study common postoperative complications. Pain 39: 275–279, 1989.
- McCracken LM, Dhingra L: A short version of the pain anxiety symptoms scale (PASS-20): Preliminary development and validity. Pain Res Manag 7: 45–50, 2002.
- Roelofs J, McCracken L, Peters ML, Crombez G, Van Breukelen G, Vlaeyen JWS: Psychometric evaluation of the pain anxiety symptoms scale (PASS) in chronic pain patients. J Behav Med 27(2): 167–183, 2004.
- Coons MJ, Hadjistavropoulos HD, Asmundson GJG: Factor structure and psychometric properties of the pain anxiety symptoms scale-20 in a community physiotherapy clinic sample. Eur J Pain 8: 511–516, 2004.
- Tarlov AR, Waring JE, Greenfield S, Nelson EC, Perrin E, Zubkoff M: The medical outcomes study: An application of methods for monitoring the results of medical care. J Am Med Assoc 262: 925–930, 1989.
- Schlenk E, Erien J, Dunbar-Jacob J, McDowell J, Engberg S, Sereika S, : Health-related quality of life in chronic disorders: A comparison across studies using the MOS SF-36. Qual Life Res 7: 57–65, 1998.
- Ware JE, Kosinski M, Keller SK: Physical and Mental Health Summary Scales: A User's Manual. The Health Institute, Boston, MA, 1994.
- Ware JF, Snow KK, Kosinski M, Gandek B: SF-36 Health Survey Manual and Interpretation Guide. New England Medical Centre, The Health Institute, Boston, MA, 1993.
- Ware JE: SF-36 health survey update. Spine 25(24): 3130–3139, 2000.
- Jason LA, Torres-Harding S, Friedberg F, Corradi K, Njoku MG, Donalek J, : Non-pharmacologic interventions for CFS: A randomized trial. J Clin Psychol Med Settings 14: 275–296, 2007.
- Knoop H, Stulemeijer M, Prins JB, Van Der Meer JWM, Bleijenberg G: Is cognitive behaviour therapy for chronic fatigue syndrome also effective for pain symptoms? Behav Res Ther 45: 2034–2043, 2007.
- Dworkin RH, Turk DC, Farrar JT, Haythorthwaite JA, Jensen MP, : Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain 113: 9–19, 2005.
- Roche PA, Klestov AC, Heim HM: Description of stable pain in rheumatoid arthritis: A 6-year study. J Rheumatol 30(8): 1733–1738, 2003.
- Svendsen KB, Jensen TS, Hansen HJ, Bach FW: Sensory function and quality of life in patients with multiple sclerosis and pain. Pain 114: 473–481, 2005.
- Moldosfsky H: Sleep and pain. Sleep Med Rev 5: 387–398, 2001.
- Morriss RK, Ahmed M, Wearden AJ, Mullis R, Strickland P, Appleby L, : The role of depression in pain, psycholphysiological syndromes, and medically unexplained symptoms associated with chronic fatigue syndrome. J Affect Disord 55: 143–148, 1999.
- Geisser M, Wiggert E, Haig A, Colwell M: A randomized, controlled trial of manual therapy and specific adjuvant exercise for chronic low back pain. Clin J Pain 21: 463–470, 2005.
- Dworkin RH: An overview of neuropathic pain: Syndromes, symptoms, signs, and several mechanisms. Clin J Pain 18: 343–349, 2002.
- Travell JG, Simons DG: Myofascial pain and dysfunction. The Trigger Point Manual. Williams & Wilkins, Baltimore, MD, 1983, pp. 53.
- Manheim C: Introduction to myofascial release. The Myofascial Release Manual, 3rd ed. SLACK, Virginia, 2001, pp. 5.
- Whiteside A, Hansen S, Chaudhuri A: Exercise lowers pain threshold in chronic fatigue syndrome. Pain 109: 497–499, 2004.
- Samad TA, Moor KA, Sapirstein A, Billet S, Allchorne A, Poole S, : Interleukin-1 beta-mediated induction of COX-2 in the CNS contributes to inflammatory pain hypersensitivity. Nature 410: 471–475, 2001.
- Dworkin RH, Backonja M, Rowbotham MC, Allen RR, Argoff CR, Bennett GJ, : Advances in neuropathic pain. Arch Neurol 60: 1524–1534, 2003.
- Boureau F, Doubrere JF, Luu M: Study of verbal description in neuropathic pain. Pain 42: 145–152, 1990.
- Rasmussen PV, Sindrup SH, Jensen TS, Bach FW: Symptoms and signs in patients with suspected neuropathic pain. Pain 110: 461–469, 2004.
- Marchettini P: The burning case of neuropathic pain wording. Pain 114: 313–314, 2005.
- Meeus M, Nijs J: Central sensitization: A biopsychosocial explanation for chronic widespread pain in patients with fibromyalgia and chronic fatigue syndrome. Clin Rheumatol 26: 465–473, 2007.
- Nijs J, Van de Velde B, De Meirleir K: Pain in patients with chronic fatigue syndrome: Does nitric oxide trigger central sensitization? Med Hypothes 64: 558–562, 2005.
- Butler D, Moseley L: Explain Pain, 1st ed. Noigroup Publications, Australia, 2003, pp. 19.
- Bombardier CH, Buchwald D: Chronic fatigue, chronic fatigue syndrome, and fibromyalgia: Disability and health-care use. Med Care 34: 924–930, 1996.
- McCrone P, Darbishire L, Ridsdale L, Seed P: The economic cost of chronic fatigue and chronic fatigue syndrome in UK primary care. Psychol Med 33: 253–261, 2003.
- Nishikai M, Tomomatsu S, Hankins RW, Takagi S, Miyachi K, Kosaka S, : Autoantibodies to a 68/48 kDa protein in chronic fatigue syndrome and primary fibromyalgia: A possible marker for hypersomnia and cognitive disorders. Rheumatology 40: 806–810, 2001.
- Jason LA, Torres-Harding SR, Carrico AW, Taylor RR: Symptom occurrence in persons with chronic fatigue syndrome. Biol Psychol 59: 15–27, 2002.